These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 25655046)

  • 21. Dramatic impact of a Psoriasis Area and Severity Index 90 response on the quality of life in patients with psoriasis: an analysis of Japanese clinical trials of infliximab.
    Torii H; Sato N; Yoshinari T; Nakagawa H;
    J Dermatol; 2012 Mar; 39(3):253-9. PubMed ID: 22211581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioelectrical phase angle and psoriasis: a novel association with psoriasis severity, quality of life and metabolic syndrome.
    Barrea L; Macchia PE; Di Somma C; Napolitano M; Balato A; Falco A; Savanelli MC; Balato N; Colao A; Savastano S
    J Transl Med; 2016 May; 14(1):130. PubMed ID: 27165166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients.
    Norlin JM; Steen Carlsson K; Persson U; Schmitt-Egenolf M
    Br J Dermatol; 2012 Apr; 166(4):797-802. PubMed ID: 22182212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal.
    Spuls PI; Hooft L
    Br J Dermatol; 2012 Oct; 167(4):710-3; discussion 714-5. PubMed ID: 23013312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
    Tang MM; Chang CC; Chan LC; Heng A
    Int J Dermatol; 2013 Mar; 52(3):314-22. PubMed ID: 23414155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psoriasis severity: commonly used clinical thresholds may not adequately convey patient impact.
    Golbari NM; van der Walt JM; Blauvelt A; Ryan C; van de Kerkhof P; Kimball AB
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):417-421. PubMed ID: 32978847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A descriptive study of psoriasis characteristics, severity and impact among 3,269 patients: results of a Belgian cross sectional study (BELPSO).
    Lambert J; Dowlatshahi EA; de la Brassinne M; Nijsten T
    Eur J Dermatol; 2012; 22(2):231-7. PubMed ID: 22266338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies.
    Mattei PL; Corey KC; Kimball AB
    J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):333-7. PubMed ID: 23425140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of CoQ10 Administration to Psoriatic Iraqi Patients on Biological Therapy Upon Severity Index (PASI) and Quality of Life Index (DLQI) Before and After Therapy.
    Al-Oudah GA; Sahib AS; Al-Hattab MK; Al-Ameedee AA
    J Popul Ther Clin Pharmacol; 2022; 29(2):e52-e60. PubMed ID: 35848197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Life quality among psoriasis patients based on Dermatology Life Quality Index evaluation and its association with psoriasis severity in China: a cross-sectional study.
    Chen Y; Wei L; Song Y; Zhang R; Kuai L; Li B; Wang R
    Ann Med; 2023 Dec; 55(1):2231847. PubMed ID: 37417705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between Dermatology Life Quality Index (DLQI) scores and Work Limitations Questionnaire (WLQ) allows the calculation of percent work productivity loss in patients with psoriasis.
    Schmitt J; Küster D
    Arch Dermatol Res; 2015 Jul; 307(5):451-3. PubMed ID: 25940274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life and related factors in a cohort of plaque-type psoriasis patients in La Coruña, Spain.
    Fernández-Torres RM; Pita-Fernández S; Fonseca E
    Int J Dermatol; 2014 Nov; 53(11):e507-11. PubMed ID: 25266080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Essential factors influencing health-related-quality of life in psoriasis.
    Rønneberg Mehren C; Clemmensen A; Boe-Hansen Dall A; Philipsen P; Gniadecki R
    J Drugs Dermatol; 2014 Mar; 13(3):246-50. PubMed ID: 24595566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the Dermatology Life Quality Index (DLQI) underestimate the disease-specific burden of psoriasis patients?
    Langenbruch A; Radtke MA; Gutknecht M; Augustin M
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):123-127. PubMed ID: 30160802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of psoriatic arthritis with nail and scalp involvement in Turkish psoriasis patients: Multicentered cross-sectional study.
    Askin O; Engin B; Ozdede A; Kartal SP; Ugurlu S; Akbulut TO; Ekinci AP; Aydogdu İH; Ozden MG; Kok H; Dogan S; Ozturkcan S; Borlu M; Baskan EB; Yilmaz N; Ak T; Topkarci Z; Serdaroglu S
    Medicine (Baltimore); 2024 Jul; 103(29):e38832. PubMed ID: 39029037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The quality of life in Italian psoriatic patients treated with biological drugs.
    Cozzani E; Borrini V; Pennella A; Burlando M; Cardo P; Rebora A; Parodi A
    G Ital Dermatol Venereol; 2010 Dec; 145(6):709-12. PubMed ID: 21139547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of health-related quality of life in psoriasis patients in Malaysia.
    Nyunt WW; Low WY; Ismail R; Sockalingam S; Min AK
    Asia Pac J Public Health; 2015 Mar; 27(2):NP662-73. PubMed ID: 23858523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis.
    Bergstrom KG; Arambula K; Kimball AB
    Cutis; 2003 Nov; 72(5):407-11. PubMed ID: 14655784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan.
    Khawaja AR; Bokhari SM; Tariq R; Atif S; Muhammad H; Faisal Q; Jafferany M
    Prim Care Companion CNS Disord; 2015; 17(3):. PubMed ID: 26644955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life and severity of skin and nail involvement in patients with plaque psoriasis.
    Kyriakou A; Patsatsi A; Sotiriadis D
    Eur J Dermatol; 2014; 24(5):623-5. PubMed ID: 25075721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.